The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs
Open accessAbstract
Despite evidence of chronic inflammation in myelodysplastic syndrome (MDS) and cell-intrinsic dysregulation of Toll-like receptor (TLR) signaling in MDS hematopoietic stem and progenitor cells (HSPCs), the mechanisms responsible for the competitive advantage of MDS HSPCs in an inflammatory milieu over normal HSPCs remain poorly defined. Here, we found that chronic inflammation was a determinant for the competitive advantage of MDS HSPCs and for disease progression. The cell-intrinsic response of MDS HSPCs, which involves signaling through the noncanonical NF-κB pathway, protected these cells from chronic inflammation as compared to normal HSPCs. In response to inflammation, MDS HSPCs switched from canonical to noncanonical NF-κB signaling, a process that was dependent on TLR-TRAF6-mediated activation of A20. The competitive advantage of TLR-TRAF6-primed HSPCs could be restored by deletion of A20 or inhibition of the noncanonical NF-κB pathway. These findings uncover the mechanistic basis for the clonal dominance of MDS HSPCs and indicate that interfering with noncanonical NF-κB signaling could prevent MDS progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and exhibit a toll-like receptor–TNF receptor associated factor 6A (TLR-TRAF6A) and noncanonical NF-κB–dependent competitive advantage during low-grade inflammation.17”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [17]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
The non-canonical NF-κB pathway in immunity and inflammation
Sun, S. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.52 · Cited by 1,959
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O’Rourke, K. M., Zhou, H., Eby, M. T., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R. T., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,889
Self-citationHaeussler, M., Schönig, K., Eckert, H., Eschstruth, A., Mianné, J., Renaud, J.-B., Schneider-Maunoury, S., Shkumatava, A., Teboul, L., Kent, J., et al. (2016) · Genome biology · doi:10.1186/s13059-016-1012-2 · Cited by 1,756
Greenberg, P. L., Attar, E. C., Bennett, J. M., Bloomfield, C. D., Borate, U., Castro, C. M. D., Deeg, H. J., Frankfurt, O., Gaensler, K. M. L., Garcia-Manero, G., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0104 · Cited by 1,625
Self-citationFailure to Regulate TNF-Induced NF-κB and Cell Death Responses in A20-Deficient Mice
Lee, E. G., Boone, D. L., Chai, S., Libby, S. L., Chien, M., Lodolce, J. P., & Ma, A. (2000) · Science · doi:10.1126/science.289.5488.2350 · Cited by 1,409
Self-citationTet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
Zhang, Q., Zhao, K., Shen, Q., Han, Y., Gu, Y., Li, X., Zhao, D., Liu, Y., Wang, C., Zhang, X., et al. (2015) · Nature · doi:10.1038/nature15252 · Cited by 807
Sato, S., Sugiyama, M., Yamamoto, M., Watanabe, Y., Kawai, T., Takeda, K., & Akira, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4304 · Cited by 730
Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
Starczynowski, D. T., Kuchenbauer, F., Argiropoulos, B., Sung, S., Morin, R., Muranyi, A., Hirst, M., Hogge, D., Marra, M., Wells, R. A., et al. (2010) · Nature Medicine · doi:10.1038/nm.2054 · Cited by 577
Self-citationInflammation: a key regulator of hematopoietic stem cell fate in health and disease
Pietras, E. M. (2017) · Blood · doi:10.1182/blood-2017-06-780882 · Cited by 417
Cited by
Sorted by citations
Items 101–155 of 155
Clonal hematopoiesis of indeterminate potential and atrial fibrillation
Liu, J., Zhang, N., Teng, G., Tse, G., Bai, J., Lip, G. Y. H., & Liu, T. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.05.011 · Cited by 4
Cavalcante, C. B. A., Chaves, A. C., de Oliveira, V. S., de Araújo, M. A. S., Silva, T. M., Goes, J. V. C., de Oliveira, R. T. G., Pinheiro, R. F., & Ribeiro, H. L. (2025) · Apmis · doi:10.1111/apm.70065 · Cited by 4
Barabino, S. M. L., Citterio, E., & Ronchi, A. E. (2021) · Cancers · doi:10.3390/cancers13153753 · Cited by 4
Chee, L. C. Y., Ritchie, D., Ludford‐Menting, M., Ripley, J., Chung, J., Park, D. J., Norton, S., Kenealy, M. K., & Koldej, R. M. (2021) · European Journal Of Haematology · doi:10.1111/ejh.13742 · Cited by 4
Mitochondrial dynamics as a pathobiological mediator of clonal myeloid disorders
Hayashi, Y., & Harada, H. (2023) · Cancer Science · doi:10.1111/cas.15810 · Cited by 3
Clones of aging: When better fitness can be dangerous
Marongiu, F., Cheri, S., & Laconi, E. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151340 · Cited by 4
Deep learning-based morphological assessment of myelodysplastic syndrome on bone marrow smears
Kaji, S., Kawai, H., Shimbo, K., Maeda, T., Matsuda, A., & Mori, J. (2025) · Leukemia Research · doi:10.1016/j.leukres.2025.107923 · Cited by 3
Lee, K., Hong, C.-L., Dissanayake, W. M., Kulzhanova, G., Pfeffer, A. N., Li, H., Sivakumar, S., Yin, Z., Quarato, E. R., Benoodt, L., et al. (2026) · Blood · doi:10.1182/blood.2024028031 · Cited by 5
Trusiano, B., Zimmerman, K., Morrison, H. A., & Allen, I. C. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae101 · Cited by 3
Low‐risk MDS—A spotlight on precision medicine for SF3B1‐mutated patients
Burke, S., Chowdhury, O., & Rouault‐Pierre, K. (2025) · HemaSphere · doi:10.1002/hem3.70103 · Cited by 4
miR-378-3p Knockdown Recapitulates Many of the Features of Myelodysplastic Syndromes
Wang, D., Lin, M., Utz, B., Bosompem, A., Guo, Y. P., Daneshbod, Y., Alford, C. E., Nettles, S. A., Scher, J., Gagne, E. Y., et al. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.07.006 · Cited by 3
Steensma, D. P. (2021) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2021.101327 · Cited by 3
Niu, H., Zhang, M., Liu, M., Yang, L., Yang, L., Ren, J., Yu, Y., Liu, Y., Xing, L., Shao, Z., et al. (2023) · Hematological Oncology · doi:10.1002/hon.3224 · Cited by 3
Autophagy Gene Panel-Based Prognostic Model in Myelodysplastic Syndrome
Wang, M., Liu, W., Wang, X., Li, Y., Xiao, H., Quan, R., Huang, G., & Hu, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.606928 · Cited by 3
Zhang, H., Zhang, L., Liang, X., Zhang, L., Ma, B., Li, Y., Wang, J., Shen, Y., Pang, Y., & Xiong, J. (2024) · Hereditas · doi:10.1186/s41065-024-00335-x · Cited by 2
Lou, J., Gong, C., Gao, X., Zhou, J., Wu, Q., Zheng, X., & Cheng, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1695754 · Cited by 2
Scaffolding-dependent CASP1 constrains excessive cell-intrinsic inflammatory signaling in leukemia
Uible, E. E., Choi, I., Clough, C. A., Hassan, A., Anandappa, A. J., Fisher, J., Karki, B., Hueneman, K. M., Choi, K., Vick, E. J., et al. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2025.12.002 · Cited by 2
Self-citationMyo-inflam: a mini review on inflammatory pathways driving scleral remodeling and axial elongation
Lin, B., Liang, W., Cai, L., Xu, M., & Li, D.-K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1786055 · Cited by 2
Down-regulation of A20 mRNA expression in peripheral blood mononuclear cells from MDS patients
Wang, K., Si, T., Wei, C., Hu, Q., Zhou, Y., & Bao, J. (2024) · Hematology · doi:10.1080/16078454.2024.2330851 · Cited by 2
The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms
Janssen, L. L. G., van Leeuwen-Kerkhoff, N., Westers, T. M., de Gruijl, T. D., & van de Loosdrecht, A. A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1414102 · Cited by 2
Than, H., Fan, X., Cheung, A. M. S., Hwang, W. Y. K., & Poon, Z. (2024) · Stem Cells · doi:10.1093/stmcls/sxae073 · Cited by 2
Ernst, M. P. T., Pronk, E., van Dijk, C., van Strien, P. M. H., van Tienhoven, T. V. D., Wevers, M. J. W., Sanders, M. A., Bindels, E. M., Speck, N. A., & Raaijmakers, M. H. G. P. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000824 · Cited by 2
Fueling clonal dominance through TRAFficking of NF-κB signaling
Ueda, K., Kumari, R., & Steidl, U. G. (2020) · Nature Immunology · doi:10.1038/s41590-020-0662-0 · Cited by 2
Passos, P. R. C., Vieira, A. A., de Melo, R. P. M., FILHO, R. F. P., Sampaio, L. G., dos Santos, H. V. G., Sampaio, L. R., Goes, J. V. C., Magalhães, S. M. M., & Pinheiro, R. F. (2025) · Hematological Oncology · doi:10.1002/hon.70104 · Cited by 1
Clonal hematopoiesis and age-associated degenerative disorders
Chanias, I., Doulberis, M., & Bonadies, N. (2026) · Leukemia Research · doi:10.1016/j.leukres.2026.108180 · Cited by 1
Arnuk, A., Han, C., Lawal, A. E., Wang, B., Karma, S., Zhang, Z., Yassouf, M. Y., Rajendran, S. H., Chandok, H., Eller, M. L., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.ady2936 · Cited by 1
Ph-chromosome-negative myeloproliferative neoplasms: clonal dynamics are the name of the game
Noorafrooz, M., Noorafrooz, R., Barosi, G., & Gale, R. P. (2026) · Blood Reviews · doi:10.1016/j.blre.2026.101385 · Cited by 1
Widjajanti, K., & Sugiyanto, E. K. (2023) · Advances in economics, business and management research/Advances in Economics, Business and Management Research · doi:10.2991/978-94-6463-154-8_18 · Cited by 1
Sim, H., Park, H. J., Park, G., Kim, Y. J., Park, W., Lee, S., & Choi, M. (2024) · eLife · doi:10.1101/2024.01.02.573827 · Cited by 1
STAT3 protects HSCs from intrinsic interferon signaling and loss of long-term blood-forming activityPreprint
Patel, B., Zhou, Y., Babcock, R. L., Ma, F., Zal, M. A., Kumar, D., Medik, Y. B., Kahn, L. M., Pineda, J. E., Park, E. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.10.528069 · Cited by 1
Sim, H., Park, H. J., Park, G., Kim, Y. J., Park, W., Lee, S., & Choi, M. (2024) · eLife · doi:10.7554/elife.96951.1 · Cited by 1
Syndromes myélodysplasiques et leucémies secondaires. Généralités, diagnostic et classification
Park, S., Cluzeau, T., Fenaux, P., & Dreyfus, F. (2014)
Indoleamine 2,3-Dioxygenase Activity Is Increased in Myelodysplastic Syndrome Patients
Yamaguchi, K., Ninomiya, S., Matsumoto, T., Nakamura, N., Nakamura, H., Kitagawa, J., Kanemura, N., Hara, T., Fujigaki, S., Yamamoto, Y., et al. (2020) · Hemato · doi:10.3390/hemato1020011
Chronic inflammation suppresses del(5q)-like MDS HSCs via p53Preprint
Muto, T., Walker, C. S., Choi, K., Niederkorn, M., Ishikawa, C., Varney, M. E., Hueneman, K. M., & Starczynowski, D. T. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.22.497183
Self-citationAoyagi, Y., Hayashi, Y., Harada, Y., Choi, K., Matsunuma, N., Sadato, D., Maemoto, Y., Ito, A., Yanagi, S., Starczynowski, D. T., et al. (2023) · doi:10.1158/2159-8290.c.6549430.v1
Self-citationChen, L., Pronk, E., van Dijk, C., Bian, Y., Feyen, J., van Tienhoven, T. V. D., Yildirim, M., Pisterzi, P., de Jong, M. M. E., Bastidas, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.05.539525
Hong, M., & Chang, C. (2023) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2023.04.018
Starodub, H. S., Басова, О. В., Goryainova, N. V., & Tretiak, N. (2023) · HEMATOLOGY AND BLOOD TRANSFUSION INTERDEPARTAMENTAL COLLECTION · doi:10.33741/0435-1991.42.19
Matsunuma, N., Hayashi, Y., Fukuda, M., Yuki, K., Kamimura-Aoyagi, Y., Kobayashi, H., Shingai, N., Harada, Y., & Harada, H. (2024) · Blood Vessels Thrombosis & Hemostasis · doi:10.1016/j.bvth.2024.100014
Sim, H., Park, H. J., Park, G.-H., et al. (2024) · eLife · doi:10.7554/elife.96951.1.sa1
Sim, H., Park, H. J., Park, G.-H., et al. (2024) · eLife · doi:10.7554/elife.96951.1.sa0
CH-related Mutant ASXL1 Promotes Atherosclerosis in Mice via Dysregulated Innate ImmunityPreprint
Sato, N., Goyama, S., Chang, Y., Fujino, T., Denda, T., Asada, S., Shikata, S., Liu, X., Yonezawa, T., Takeda, R., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.18.608516
Sim, H., Park, H. J., Park, G., Kim, Y. J., Park, W., Lee, S., & Choi, M. (2024) · eLife · doi:10.7554/elife.96951.2
MYD88 mutations in clonal hematopoiesis promote inflammation and hematopoietic stem cell expansionPreprint
Yeung, J., Philbrook, S. Y., Uible, E. E., Lee, L. H., Choi, K., Agarwal, P., Clough, C. A., Patel, P., Wikenheiser‐Brokamp, K. A., Hueneman, K. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.19.660202 · Cited by 1
Self-citationMyelodysplastic Syndrome in a Patient With Cronkhite‐Canada Syndrome
Shim, K. G., Khadarian, K. A., Samadder, J. J., Zhou, J., & Yi, C. A. (2025) · Clinical Case Reports · doi:10.1002/ccr3.70602
Umar, Y. J., Savvopoulos, S., Pitsalidis, C., Mitroulis, I., & Hatzikirou, H. (2026) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2026.112487
A20 restriction of nitric oxide production restores macrophage bioenergetic balancePreprint
Chan, M.-P., Advincula, R., Achacoso, P., Grossman, E. A., Nomura, D. K., Malynn, B. A., & Ma, A. I. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.26.684676
Self-citationUnveiling Cancer's Molecular Tapestry
Singh, F., Joshi, P., Farheen, F., Gour, P., Jain, V. K., & Sharma, P. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814113126010004
Aging in the bone marrow: when hematopoiesis gets clonal
Bowdish, D. M. E., & Quin, C. (2026) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000928
List, A. F. (2026) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/s2152-2650(26)00311-3
Chen, J., Lee, K., Adapathya, R., Hong, C.-L., & Yeh, S.-C. A. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5591-7_8
Metadata
- Authors
- Muto, T., Walker, C. S., Choi, K., Hueneman, K., Smith, M. A., Gul, Z., Garcia-Manero, G., Ma, A., Zheng, Y., & Starczynowski, D. T.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- University of Cincinnati (US)
- University of California, San Francisco (US)
- Corresponding author
- Starczynowski, Daniel T.
- ORCID
- Venue
- Nature Immunology
- Published
- 2020-04-20
- Volume
- 21
- Issue
- 5
- Pages
- 535-545
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC7402480
- OpenAlex
- W3017327186
- Cited by
- 155
- References
- 59
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 30 · 2023: 24 · 2022: 24 · 2021: 28 · 2020: 16
- FWCI
- 14.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R35HL135787)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK102759, R01DK113639)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- myelodysplastic syndrome, hematopoietic stem and progenitor cells, chronic inflammation, non-canonical NF-κB signaling, Toll-like receptor signaling, TRAF6, A20, clonal dominance, myelopoiesis, disease progression, competitive advantage
- MeSH terms
- Tumor Necrosis Factor alpha-Induced Protein 3, Aged, Animals, Cell Differentiation, Cells, Cultured, Hematopoietic Stem Cells, Humans, Inflammation, Male, Mice, Transgenic, Myelodysplastic Syndromes, Signal Transduction, NF-kappa B, Myelopoiesis, TNF Receptor-Associated Factor 6, Toll-Like Receptors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
